Taken together, these results indicate that ALKBH5-mediated m6A modification increases CASC8 levels in ESCC and that overexpression of CASC8 facilitates ESCC progression and chemoresistance to cisplatin by interacting with hnRNPL [107]. The gene discussed is ALKBH5; the disease is esophageal squamous cell carcinoma.